Aberrant expression of Wnt and Notch signal pathways in Barrett’s esophagus - 05/11/12
Corresponding author. Tel.: +086 25 58509932; fax: +086 25 58509931.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 11 |
| Iconographies | 6 |
| Vidéos | 0 |
| Autres | 0 |
Summary |
Background |
Specialized intestinal metaplasia (SIM) mucosa observed in Barrett’s esophagus (BE) has been a hot research topic due to the close relationship with adenocarcinoma of esophagus (ACE). Earlier studies found that SIM mucosa was similar to normal intestinal epithelium on morphology and histology. The signal pathway involved in conformation of intestinal epithelium may be a critical initiator for BE.
Methods |
The expressions of key regulators (Tcf4, Cdx2, Hes1 and Math1) in Wnt and Notch signal pathways were measured in 41 paired esophageal biopsies. Cell morphological changes in normal esophagus were compared among groups treated by acid, bile acid and the mixture of both media.
Results |
The expression levels of regulators (Tcf4, Cdx2, Hes1 and Math1) were found significantly increased in SIM, C≥3Mn and high-grade dysplasia (HGD) groups. Distinct ultrastructure changes and highly expressed key regulators were also detected at the seventh day for group treated by 400μmol bile acid.
Conclusions |
Aberrant expressed regulators in Wnt and Notch pathways were observed in BE tissue and normal esophageal cells treated by acid, bile acid and the mixture of both media. This study provided preliminary data to understand the mechanism of BE conformation.
Le texte complet de cet article est disponible en PDF.Plan
Vol 36 - N° 5
P. 473-483 - octobre 2012 Retour au numéro
Article précédent
- MELD-based graft allocation system fails to improve liver transplantation efficacy in a single-center intent-to-treat analysis
- Vianney Bouygues, Philippe Compagnon, Marianne Latournerie, Edouard Bardou-Jacquet, Christophe Camus, Mohamed Lakehal, Bernard Meunier, Karim Boudjema
- Efficacy and safety evaluation of two doses of imatinib for the treatment of advanced gastrointestinal stromal tumors (GISTs)
- Ping Yang, Bo Chen, Yong Zhou, Xiao-Ting Wu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?